Health - Latest News Search Engine - Global and Local Breaking News

Health

Medicilon успешно прошла проверку FDA, укрепив глобальное признание своих достижений в области исследований и разработок

БОСТОН, 2 июня 2025 г. /PRNewswire/ -- 20 мая компания Medicilon Preclinical Research (Shanghai) LLC («Medicilon») объявила о завершении проведения FD...

Medicilon успешно прошла проверку FDA, укрепив глобальное признание своих достижений в области исследований и разработок

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio PARIS and CAMBRIDGE, Mass., June ...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea , June 1, 2025 /PRNewswire/ -- J INTS BIO, a company sp...

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-c...

Pharmacists warn drug shortage affecting cancer patients

Some patients are skipping meals due to a shortage of Creon, says a pharmacy association.

Pharmacists warn drug shortage affecting cancer patients

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) f...

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical co...

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with ...

Conference call and webcast to be held at 8:30 a.m. ET NEW HAVEN, Conn., June 1, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clini...

Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

SIBIONICS Hosts the 3rd AGP&DTx Summit Forum: Breakthroughs Ahead

SHENZHEN, China, June 1, 2025 /PRNewswire/ -- On May 31, SIBIONICS Successfully Hosts the 3rd AGP & DTx Summit Forum in Shenzhen, China, bringing ...

SIBIONICS Hosts the 3rd AGP&DTx Summit Forum: Breakthroughs Ahead

The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program

GAINESVILLE, Fla., June 1, 2025 /PRNewswire/ -- The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a gr...

The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Oncologist Dr. Asma Dilawari and palliative care physician Dr. Nelia Jain join to expand survivorship program and scale supportive care and palliative...

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology

PRINCETON, N.J. and CAMBRIDGE, Mass., June 1, 2025 /PRNewswire/ -- Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., announced today the publicat...

Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology

Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer

Pasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community setting D...

Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer trea...

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

La National Hispanic Health Foundation inicia un nuevo y audaz capítulo para crear un sistema de salud sostenible para todos

WASHINGTON, 31 de mayo de 2025 /PRNewswire-HISPANIC PR WIRE/ -- La National Hispanic Health Foundation (NHHF), anteriormente parte de la National Hisp...

La National Hispanic Health Foundation inicia un nuevo y audaz capítulo para crear un sistema de salud sostenible para todos

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) ...

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company ...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma

Ranganathan opens up about mental health struggle

The comedian says he hopes to destigmatise mental health issues by being open about his own experiences.

Ranganathan opens up about mental health struggle

Novoxel Inc. and GPOphtho Finalize Strategic Agreement to Deliver Breakthrough Dry Eye Treatments and Aesthetic Procedures to Eyecare Physicians Natio...

KNOXVILLE, Tenn., May 31, 2025 /PRNewswire/ -- Novoxel Inc. and GPOphtho announce their agreement to expand access to Novoxel's innovative Tixel® devi...

Novoxel Inc. and GPOphtho Finalize Strategic Agreement to Deliver Breakthrough Dry Eye Treatments and Aesthetic Procedures to Eyecare Physicians Nationwide

People say coke and fries are helping their migraines - but there's a twist

Migraines are one of the most complex neurological disorders. What is the science behind the latest hack?

People say coke and fries are helping their migraines - but there's a twist

Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session

NANJING, China, May 31, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clin...

Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session

Disposable vape ban begins but will teens quit?

Retailers will no longer be able to sell single-use vapes as new laws comes into force across the UK.

Disposable vape ban begins but will teens quit?